Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Urologic Diseases 1Pancreatic Neoplasms 1Nephritis 1Neoplasms 1Melanoma 1Mastocytosis 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Kidney Diseases 1Immune System Diseases 1Hypoxia 1Glomerulonephritis, IGA 1Glomerulonephritis 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Autoimmune Diseases 1

Interventions

TH 302 2Radiotherapy 2pomalidomide 1pimonidazole 1inositol trispyrophosphate 1fluoroazomycin arabinoside 1Thoracotomy 1Thoracic Surgery, Video-Assisted 1Propofol 1Positron Emission Tomography Computed Tomography 1Nimorazole 1Metformin 1Letrozole 1Ipilimumab 1Hydroxychloroquine 1Drug Therapy 1Diagnostic Imaging 1Dexamethasone 1Circulating Tumor DNA 1Bortezomib 1AQ4N 14-methylbenzenesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hypoxia × Hydroxychloroquine × Clear all
NCT01292408 2012-01-20

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Radboud University Medical Center

Phase 2 Unknown
20 enrolled
Breast

Hypoxia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡